Scientists probe muscle loss in ICU patients with novel tracer technique
NCT ID NCT03451968
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to understand how amino acids are processed differently in critically ill patients who have been in the ICU for more than 7 days compared to healthy volunteers. Researchers will inject stable (non-radioactive) amino acid tracers and take multiple blood samples over 3 hours to measure metabolism. The goal is to gather knowledge that could eventually lead to better nutritional support or treatments to prevent muscle wasting in long-stay ICU patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- stable amino acid tracers (injected)
- What this could lead to
- If successful, this could help guide future treatments to prevent muscle wasting in long-term ICU patients.
- What could go wrong
- This is a small, early observational study with only 30 participants. It measures metabolism but does not test any treatment, so direct patient benefits are not expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLISM AND NUTRITION DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rabin medical center
RECRUITINGPetah Tikva, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.